Compare 3M Company (MMM) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
3M Company vs Tempus AI — how do they compare? 3M Company trades at $163.73 (market cap $83.61B), while Tempus AI trades at $70 (market cap $12.77B). The key difference: 3M Company is far larger — about 6.5× Tempus AI's market cap, and 3M Company pays a 1.92% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold 3M Company for 169 Days and Tempus AI for 22 Days on average.
| MMM | TEM | |
|---|---|---|
Market Cap | $83.61B | $12.77B |
Volume | 3,188,723 | 8,980,490 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $183.79 | $99.28 |
52-Week Low | $141.10 | $41.55 |
Typical Hold Time | 169 Days | 22 Days |
Enterprise Value | $92.83B | $13.40B |
Dividend Yield | 1.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
3M (MMM) trades at $163.57, showing minimal daily movement (-0.04%) amid a bearish technical outlook. The company demonstrates strong profitability with 11.9% net margins and impressive ROE of 82.77%, though revenue has declined from 2022 peaks. Recent Q2 2026 earnings beat expectations with 5.4% organic growth, supporting management's turnaround narrative. Analyst sentiment is evenly split between Buy and Hold ratings with a $191 consensus target representing 17% upside potential.
The stock presents a value opportunity with manageable litigation risks, but faces headwinds from weak consumer demand and high debt levels. Near-term catalysts include continued operational improvements and data-center expansion, while risks center on execution of margin targets and macroeconomic pressures on industrial markets.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 3M Company
3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
